Search Results

There are 4839 results for: content related to: Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia

  1. You have free access to this content
    Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management

    American Journal of Hematology

    Volume 87, Issue 6, June 2012, Pages: 610–619, Sameer A. Parikh and Ayalew Tefferi*

    Article first published online : 21 MAY 2012, DOI: 10.1002/ajh.23203

  2. You have free access to this content
    Activity of azacitidine in chronic myelomonocytic leukemia

    Cancer

    Volume 117, Issue 12, 15 June 2011, Pages: 2690–2696, Rubens Costa, Haifaa Abdulhaq, Bushra Haq, Richard K. Shadduck, Joan Latsko, Mazen Zenati, Folefac D. Atem, James M. Rossetti, Entezam A. Sahovic and John Lister

    Article first published online : 23 DEC 2010, DOI: 10.1002/cncr.25759

  3. You have free access to this content
    Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia

    British Journal of Haematology

    Volume 153, Issue 2, April 2011, Pages: 149–167, Ulrike Bacher, Torsten Haferlach, Susanne Schnittger, Hans Kreipe and Nicolaus Kröger

    Article first published online : 9 MAR 2011, DOI: 10.1111/j.1365-2141.2011.08631.x

  4. You have free access to this content
    Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

    Cancer

    Volume 116, Issue 16, 15 August 2010, Pages: 3830–3834, Elias Jabbour, Guillermo Garcia-Manero, Nicolas Batty, Jenny Shan, Susan O'Brien, Jorge Cortes, Farhad Ravandi, Jean-Pierre Issa and Hagop Kantarjian

    Article first published online : 17 MAY 2010, DOI: 10.1002/cncr.25247

  5. You have free access to this content
    Update of the decitabine experience in higher risk myelodysplastic syndrome and analysis of prognostic factors associated with outcome

    Cancer

    Volume 109, Issue 2, 15 January 2007, Pages: 265–273, Hagop M. Kantarjian, Susan O'Brien, Jianqin Shan, Ahmed Aribi, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Jorge Cortes, Jan Davisson and Jean-Pierre Issa

    Article first published online : 28 NOV 2006, DOI: 10.1002/cncr.22376

  6. Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndrome

    European Journal of Haematology

    Volume 94, Issue 6, June 2015, Pages: 546–553, Je-Hwan Lee, Yunsuk Choi, Sung-Doo Kim, Dae-Young Kim, Jung-Hee Lee, Kyoo-Hyung Lee, Sang-Min Lee, Won-Sik Lee and Young-Don Joo

    Article first published online : 7 JAN 2015, DOI: 10.1111/ejh.12469

  7. You have free access to this content
    Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management

    American Journal of Hematology

    Volume 88, Issue 11, November 2013, Pages: 967–974, Sameer A. Parikh and Ayalew Tefferi

    Article first published online : 24 OCT 2013, DOI: 10.1002/ajh.23574

  8. You have free access to this content
    Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review

    British Journal of Haematology

    Volume 165, Issue 3, May 2014, Pages: 273–286, Mrinal M. Patnaik, Sameer A. Parikh, Curtis A. Hanson and Ayalew Tefferi

    Article first published online : 28 JAN 2014, DOI: 10.1111/bjh.12756

  9. Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome

    American Journal of Hematology

    Volume 90, Issue 5, May 2015, Pages: 411–416, Mrinal M. Patnaik, Emnet A. Wassie, Terra L. Lasho, Curtis A. Hanson, Rhett Ketterling and Ayalew Tefferi

    Article first published online : 1 APR 2015, DOI: 10.1002/ajh.23962

  10. You have free access to this content
    Decitabine improves patient outcomes in myelodysplastic syndromes

    Cancer

    Volume 106, Issue 8, 15 April 2006, Pages: 1794–1803, Hagop Kantarjian, Jean-Pierre J. Issa, Craig S. Rosenfeld, John M. Bennett, Maher Albitar, John DiPersio, Virginia Klimek, James Slack, Carlos de Castro, Farhad Ravandi, Richard Helmer III, Lanlan Shen, Stephen D. Nimer, Richard Leavitt, Azra Raza and Hussain Saba

    Article first published online : 13 MAR 2006, DOI: 10.1002/cncr.21792

  11. You have free access to this content
    Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia

    Cancer

    Volume 107, Issue 7, 1 October 2006, Pages: 1525–1529, Alfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Francis Giles, Farhad Ravandi, Stefan Faderl, Sherry Pierce, Jenny Shan, Srdan Verstovsek and Jorge Cortes

    Article first published online : 5 SEP 2006, DOI: 10.1002/cncr.22186

  12. Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

    British Journal of Haematology

    Volume 171, Issue 2, October 2015, Pages: 239–246, Argiris Symeonidis, Anja van Biezen, Liesbeth de Wreede, Alfonso Piciocchi, Juergen Finke, Dietrich Beelen, Martin Bornhäuser, Jan Cornelissen, Liisa Volin, Ghulam Mufti, Yves Chalandon, Arnold Ganser, Benedetto Bruno, Dietger Niederwieser, Guido Kobbe, Rainer Schwerdtfeger, Theo de Witte, Marie Robin, Nicolaus Kröger and for the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

    Article first published online : 26 JUL 2015, DOI: 10.1111/bjh.13576

  13. You have free access to this content
    Evolution of decitabine development

    Cancer

    Volume 112, Issue 11, 1 June 2008, Pages: 2341–2351, Elias Jabbour, Jean-Pierre Issa, Guillermo Garcia-Manero and Hagop Kantarjian

    Article first published online : 8 APR 2008, DOI: 10.1002/cncr.23463

  14. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response

    European Journal of Haematology

    Volume 95, Issue 2, August 2015, Pages: 168–176, Qi Shen, Juan Ouyang, Guilin Tang, Elias J. Jabbour, Guillermo Garcia-Manero, Mark Routbort, Sergej Konoplev, Carlos Bueso-Ramos, L. Jeffrey Medeiros, Jeffrey L. Jorgensen and Sa A. Wang

    Article first published online : 17 APR 2015, DOI: 10.1111/ejh.12477

  15. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire

    European Journal of Haematology

    Volume 90, Issue 5, May 2013, Pages: 355–364, Sophie Park, Myriam Labopin, Ibrahim Yakoub-Agha, Jacques Delaunay, Nathalie Dhedin, Eric Deconinck, Mauricette Michallet, Marie Robin, Thierry De Revel, Marc Bernard, Norbert Vey, Bruno Lioure, Simona Lapusan, Reza Tabrizi, Jean-Henri Bourhis, Anne Huynh, Yves Beguin, Gérard Socié, François Dreyfus, Pierre Fenaux and Mohamad Mohty

    Article first published online : 7 MAR 2013, DOI: 10.1111/ejh.12073

  16. You have free access to this content
    Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

    British Journal of Haematology

    Volume 155, Issue 5, December 2011, Pages: 599–606, Lieke H. van der Helm, Canan Alhan, Pierre W. Wijermans, Marinus van Marwijk Kooy, Ron Schaafsma, Bart J. Biemond, Aart Beeker, Mels Hoogendoorn, Bastiaan P. van Rees, Okke de Weerdt, Jurgen Wegman, Ward J. Libourel, Sylvia A. Luykx-de Bakker, Monique C. Minnema, Rolf E. Brouwer, Fransien Croon-de Boer, Matthijs Eefting, Kon-Siong G. Jie, Arjan A. van de Loosdrecht, Jan Koedam, Nic J. G. M Veeger, Edo Vellenga and Gerwin Huls

    Article first published online : 8 OCT 2011, DOI: 10.1111/j.1365-2141.2011.08893.x

  17. You have free access to this content
    Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome

    Cancer

    Volume 109, Issue 6, 15 March 2007, Pages: 1133–1137, Hagop M. Kantarjian, Susan O'Brien, Xuelin Huang, Guillermo Garcia-Manero, Farhad Ravandi, Jorge Cortes, Jianqin Shan, Jan Davisson, Carlos E. Bueso-Ramos and Jean-Pierre Issa

    Article first published online : 21 FEB 2007, DOI: 10.1002/cncr.22508

  18. You have free access to this content
    Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo

    International Journal of Cancer

    Volume 131, Issue 1, 1 July 2012, Pages: 18–29, Oscar Alcazar, Susan Achberger, Wayne Aldrich, Zhenbo Hu, Soledad Negrotto, Yogen Saunthararajah and Pierre Triozzi

    Article first published online : 6 SEP 2011, DOI: 10.1002/ijc.26320

  19. You have free access to this content
    Safety and clinical activity of 5-aza-2′-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia

    British Journal of Haematology

    Volume 167, Issue 3, November 2014, Pages: 356–365, Christopher B. Benton, Deborah A. Thomas, Hui Yang, Farhad Ravandi, Michael Rytting, Susan O'Brien, Anna R. Franklin, Gautam Borthakur, Samuel Dara, Monica Kwari, Sherry R. Pierce, Elias Jabbour, Hagop Kantarjian and Guillermo Garcia-Manero

    Article first published online : 26 JUL 2014, DOI: 10.1111/bjh.13050

  20. You have full text access to this Open Access content
    Phase I/II study of decitabine in patients with myelodysplastic syndrome: A multi-center study in Japan

    Cancer Science

    Volume 103, Issue 10, October 2012, Pages: 1839–1847, Yasuhiro Oki, Yutaka Kondo, Kazuhito Yamamoto, Michinori Ogura, Masanobu Kasai, Yukio Kobayashi, Takashi Watanabe, Naokuni Uike, Kazuma Ohyashiki, Shin-ichiro Okamoto, Kazunori Ohnishi, Akihiro Tomita, Yasushi Miyazaki, Kaoru Tohyama, Harumi Y. Mukai, Tomomitsu Hotta and Masao Tomonaga

    Article first published online : 14 SEP 2012, DOI: 10.1111/j.1349-7006.2012.02386.x